Go Back
Phosphorylations for 'GAB1'
| Source | Sequence | Kinase Gene | Detection Level | Kinase Description | Reference | Experiment type |
|---|---|---|---|---|---|---|
| Y 48 (2,1) | ||||||
| DPDVLEYYKNDHAKK | ||||||
| Y 183 (2,1) | ||||||
| IQEDPQDYLLLINCQ | ||||||
| Y 242 (2,1) | ||||||
| FFQQQMIYDSPPSRA | INSR | insulin receptor | ||||
| FFQQQMIYDSPPSRA | INSR | insulin receptor | ||||
| FFQQQMIYDSPPSRA | SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | ||||
| Y 259 (2,1) | ||||||
| ASVDSSLYNLPRSYS | ||||||
| ASVDSSLYNLPRSYS | SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | ||||
| S 266 (2,1) | ||||||
| YNLPRSYSHDVLPKV | ||||||
| YNLPRSYSHDVLPKV | ||||||
| Y 285 (2,1) | ||||||
| TEADGELYVFNTPSG | EGFR | epidermal growth factor receptor | ||||
| TEADGELYVFNTPSG | EGFR | epidermal growth factor receptor | ||||
| TEADGELYVFNTPSG | INSR | insulin receptor | ||||
| TEADGELYVFNTPSG | INSR | insulin receptor | ||||
| TEADGELYVFNTPSG | MET | met proto-oncogene (hepatocyte growth factor receptor) | ||||
| Y 307 (2,1) | ||||||
| MRHVSISYDIPPTPG | ||||||
| MRHVSISYDIPPTPG | EGFR | epidermal growth factor receptor | ||||
| MRHVSISYDIPPTPG | MET | met proto-oncogene (hepatocyte growth factor receptor) | ||||
| T 312 (1,2) | ||||||
| ISYDIPPTPGNTYQI | MAPK1 | mitogen-activated protein kinase 1 | ||||
| ISYDIPPTPGNTYQI | MAPK3 | mitogen-activated protein kinase 3 | ||||
| Y 317 (2,1) | ||||||
| PPTPGNTYQIPRTFP | ||||||
| PPTPGNTYQIPRTFP | SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | ||||
| S 355 (2,1) | ||||||
| PHPAHDRSPVETCSI | ||||||
| PHPAHDRSPVETCSI | ||||||
| Y 373 (1) | ||||||
| ASDTDSSYCIPTAGM | EGFR | epidermal growth factor receptor | ||||
| ASDTDSSYCIPTAGM | EGFR | epidermal growth factor receptor | ||||
| ASDTDSSYCIPTAGM | INSR | insulin receptor | ||||
| ASDTDSSYCIPTAGM | INSR | insulin receptor | ||||
| ASDTDSSYCIPTAGM | MET | met proto-oncogene (hepatocyte growth factor receptor) | ||||
| ASDTDSSYCIPTAGM | SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | ||||
| S 381 (1,2) | ||||||
| CIPTAGMSPSRSNTI | MAPK1 | mitogen-activated protein kinase 1 | ||||
| CIPTAGMSPSRSNTI | MAPK3 | mitogen-activated protein kinase 3 | ||||
| Y 405 (2,1) | ||||||
| KDASSQDCYDIPRAF | ||||||
| Y 406 (2,1) | ||||||
| DASSQDCYDIPRAFP | EGFR | epidermal growth factor receptor | ||||
| DASSQDCYDIPRAFP | EGFR | epidermal growth factor receptor | ||||
| DASSQDCYDIPRAFP | MET | met proto-oncogene (hepatocyte growth factor receptor) | ||||
| S 418 (2,1) | ||||||
| AFPSDRSSSLEGFHN | ||||||
| S 419 (2,1) | ||||||
| FPSDRSSSLEGFHNH | ||||||
| Y 447 (2,1) | ||||||
| SEELDENYVPMNPNS | EGFR | epidermal growth factor receptor | ||||
| SEELDENYVPMNPNS | EGFR | epidermal growth factor receptor | ||||
| SEELDENYVPMNPNS | INSR | insulin receptor | ||||
| SEELDENYVPMNPNS | INSR | insulin receptor | ||||
| SEELDENYVPMNPNS | MET | met proto-oncogene (hepatocyte growth factor receptor) | ||||
| S 454 (1,2) | ||||||
| YVPMNPNSPPRQHSS | MAPK1 | mitogen-activated protein kinase 1 | ||||
| YVPMNPNSPPRQHSS | MAPK3 | mitogen-activated protein kinase 3 | ||||
| Y 472 (2,1) | ||||||
| EPIQEANYVPMTPGT | EGFR | epidermal growth factor receptor | ||||
| EPIQEANYVPMTPGT | EGFR | epidermal growth factor receptor | ||||
| EPIQEANYVPMTPGT | INSR | insulin receptor | ||||
| EPIQEANYVPMTPGT | INSR | insulin receptor | ||||
| EPIQEANYVPMTPGT | MET | met proto-oncogene (hepatocyte growth factor receptor) | ||||
| T 476 (1,2) | ||||||
| EANYVPMTPGTFDFS | MAPK1 | mitogen-activated protein kinase 1 | ||||
| EANYVPMTPGTFDFS | MAPK1 | mitogen-activated protein kinase 1 | ||||
| EANYVPMTPGTFDFS | MAPK3 | mitogen-activated protein kinase 3 | ||||
| S 547 (2) | ||||||
| HGLERTDSQTIGDFA | ||||||
| HGLERTDSQTIGDFA | ||||||
| S 551 (1) | ||||||
| ELQAPVRSPITRSFA | ||||||
| ELQAPVRSPITRSFA | MAPK1 | mitogen-activated protein kinase 1 | ||||
| ELQAPVRSPITRSFA | MAPK3 | mitogen-activated protein kinase 3 | ||||
| S 567 (1) | ||||||
| DSSRFPMSPRPDSVH | MAPK1 | mitogen-activated protein kinase 1 | ||||
| DSSRFPMSPRPDSVH | MAPK3 | mitogen-activated protein kinase 3 | ||||
| S 581 (2) | ||||||
| ELQAPVRSPITRSFA | ||||||
| ELQAPVRSPITRSFA | MAPK1 | mitogen-activated protein kinase 1 | ||||
| ELQAPVRSPITRSFA | MAPK3 | mitogen-activated protein kinase 3 | ||||
| Y 589 (1) | ||||||
| SHDSEENYVPMNPNL | EGFR | epidermal growth factor receptor | ||||
| SHDSEENYVPMNPNL | EGFR | epidermal growth factor receptor | ||||
| SHDSEENYVPMNPNL | INSR | insulin receptor | ||||
| SHDSEENYVPMNPNL | INSR | insulin receptor | ||||
| SHDSEENYVPMNPNL | MET | met proto-oncogene (hepatocyte growth factor receptor) | ||||
| SHDSEENYVPMNPNL | PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | ||||
| S 597 (2) | ||||||
| DSSRFPMSPRPDSVH | MAPK1 | mitogen-activated protein kinase 1 | ||||
| DSSRFPMSPRPDSVH | MAPK3 | mitogen-activated protein kinase 3 | ||||
| Y 619 (2) | ||||||
| SHDSEENYVPMNPNL | EGFR | epidermal growth factor receptor | ||||
| SHDSEENYVPMNPNL | EGFR | epidermal growth factor receptor | ||||
| SHDSEENYVPMNPNL | INSR | insulin receptor | ||||
| SHDSEENYVPMNPNL | INSR | insulin receptor | ||||
| SHDSEENYVPMNPNL | MET | met proto-oncogene (hepatocyte growth factor receptor) | ||||
| Y 627 (1) | ||||||
| KGDKQVEYLDLDLDS | EGFR | epidermal growth factor receptor | ||||
| KGDKQVEYLDLDLDS | EGFR | epidermal growth factor receptor | ||||
| KGDKQVEYLDLDLDS | INSR | insulin receptor | ||||
| KGDKQVEYLDLDLDS | INSR | insulin receptor | ||||
| KGDKQVEYLDLDLDS | MET | met proto-oncogene (hepatocyte growth factor receptor) | ||||
| KGDKQVEYLDLDLDS | PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | ||||
| KGDKQVEYLDLDLDS | SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | ||||
| S 634 (1) | ||||||
| YLDLDLDSGKSTPPR | ||||||
| S 637 (1) | ||||||
| LDLDSGKSTPPRKQK | ||||||
| T 638 (1) | ||||||
| DLDSGKSTPPRKQKS | ||||||
| Y 657 (2) | ||||||
| KGDKQVEYLDLDLDS | EGFR | epidermal growth factor receptor | ||||
| KGDKQVEYLDLDLDS | EGFR | epidermal growth factor receptor | ||||
| KGDKQVEYLDLDLDS | INSR | insulin receptor | ||||
| KGDKQVEYLDLDLDS | INSR | insulin receptor | ||||
| KGDKQVEYLDLDLDS | MET | met proto-oncogene (hepatocyte growth factor receptor) | ||||
| KGDKQVEYLDLDLDS | PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | ||||
| KGDKQVEYLDLDLDS | SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | ||||
| Y 658 (1) | ||||||
| SVADERVDYVVVDQQ | ||||||
| Y 659 (1) | ||||||
| VADERVDYVVVDQQK | EGFR | epidermal growth factor receptor | ||||
| VADERVDYVVVDQQK | EGFR | epidermal growth factor receptor | ||||
| VADERVDYVVVDQQK | INSR | insulin receptor | ||||
| VADERVDYVVVDQQK | INSR | insulin receptor | ||||
| VADERVDYVVVDQQK | MET | met proto-oncogene (hepatocyte growth factor receptor) | ||||
| VADERVDYVVVDQQK | PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | ||||
| S 664 (2) | ||||||
| YLDLDLDSGKSTPPR | ||||||
| S 667 (2) | ||||||
| LDLDSGKSTPPRKQK | ||||||
| T 668 (2) | ||||||
| DLDSGKSTPPRKQKS | ||||||
| T 684 (1) | ||||||
| WTDGRQSTESETPAK | ||||||
| Y 688 (2) | ||||||
| SVADERVDYVVVDQQ | ||||||
| Y 689 (2) | ||||||
| VADERVDYVVVDQQK | EGFR | epidermal growth factor receptor | ||||
| VADERVDYVVVDQQK | EGFR | epidermal growth factor receptor | ||||
| VADERVDYVVVDQQK | INSR | insulin receptor | ||||
| VADERVDYVVVDQQK | INSR | insulin receptor | ||||
| VADERVDYVVVDQQK | MET | met proto-oncogene (hepatocyte growth factor receptor) | ||||
| VADERVDYVVVDQQK | PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | ||||
| T 714 (2) | ||||||
| WTDGRQSTESETPAK |